HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

influenza matrix peptide (58-66)

capable of being presented by class I major histocompatibility antigens
Also Known As:
GILGFVFTL; Gly-Ile-Leu-Gly-Phe-Val-Phe-Thr-Leu; glycyl-isoleucyl-leucyl-glycyl-phenylalanyl-valyl-phenylalanyl-threonyl-leucine; influenza matrix peptide 58-66
Networked: 14 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Maraskovsky, Eugene: 2 articles (03/2005 - 07/2003)
2. Hopkins, Wendie: 2 articles (03/2005 - 07/2003)
3. Jackson, Heather: 2 articles (03/2005 - 07/2003)
4. Chen, Qiyuan: 2 articles (03/2005 - 07/2003)
5. Davis, Ian D: 2 articles (03/2005 - 07/2003)
6. Cebon, Jonathan: 2 articles (03/2005 - 07/2003)
7. Sturrock, Sue: 2 articles (03/2005 - 07/2003)
8. Hückelhoven, Angela G: 1 article (08/2015)
9. Mueller-Schmucker, Sandra M: 1 article (08/2015)
10. Harrer, Thomas: 1 article (08/2015)

Related Diseases

1. Melanoma (Melanoma, Malignant)
2. Human Influenza (Influenza)
3. Small Cell Lung Carcinoma (Small Cell Lung Cancer)
4. Neoplasms (Cancer)
5. Lung Neoplasms (Lung Cancer)

Related Drugs and Biologics

1. HLA-A2 Antigen (HLA A2 Antigen)
2. Peptides
3. MART-1 Antigen
4. Antigens
5. human immunodeficiency virus p17 gag peptide
6. HLA-A*0201 antigen
7. HLA-A Antigens (HLA-A)
8. Monophenol Monooxygenase (Tyrosinase)
9. Tuberculin (PPD)
10. Tetanus Toxoid (Vaccine, Tetanus)